UB Therapeutics
Nazareth
About UB Therapeutics
UB Therapeutics is a biotechnology company developing a novel therapy for the treatment of multiple myeloma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $415.4K
- Funding stage: Seed
- Last round: Pre-Seed (Feb 2023)
- Website: ngt-healthcare2.comub-therapeutics
Industries & Categories
Health Care, Medical, Pharmaceutical, Wellness
Canonical: https://fsome.com/organization/ub-therapeutics-172468 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.